Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GPOs Maintain Practices Are Fair As Hill Members Wait On HHS IG Report

This article was originally published in The Gray Sheet

Executive Summary

An HHS Office of Inspector General audit report on group purchasing organization business practices is expected to be released in draft form in May

You may also be interested in...



Premier Purchasing Deal Almost A Given For M2A Camera Capsule Maker

Premier's two-year agreement with Given Imaging for the M2A wireless endoscopy diagnostic imaging capsule may lend support to the group purchasing organization's claim that is does not exclude smaller firms with emerging technologies

Group purchasing organizations

Senate Judiciary/Antitrust, Business Rights and Competition Subcommittee Chairman Herb Kohl (D-Wisc.) and Ranking member Mike DeWine (R-Ohio) announce they will hold a hearing this year on GPOs and their effect on competition in the medical technology marketplace. The Medical Device Manufacturers Association volunteers to help the subcommittee investigate "the anti-competitive business practices" of some of the larger GPOs. The hearing will likely take place following the August recess, MDMA notes

GPO Administrative Fees Fall Within Safe Harbor Provision, OIG Concludes

A May 22 HHS Office of the Inspector General advisory opinion supports administrative fees as long as they meet group purchasing organization (GPO) safe-harbor requirements.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016187

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel